Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (QoQ) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.85% |
| Dec 31, 2025 | 8,927.60% |
| Sep 30, 2025 | 108.46% |
| Jun 30, 2025 | -1,100.76% |
| Mar 31, 2025 | -114.52% |
| Dec 31, 2024 | 51.80% |
| Sep 30, 2024 | -98.27% |
| Jun 30, 2024 | 21,617.84% |
| Mar 31, 2024 | -72.43% |
| Dec 31, 2023 | 35.32% |
| Sep 30, 2023 | 12.01% |
| Jun 30, 2023 | 23.09% |
| Mar 31, 2023 | 101.99% |
| Dec 31, 2022 | -22,580.86% |
| Sep 30, 2022 | -68.99% |
| Jun 30, 2022 | 4.00% |
| Mar 31, 2022 | -92.79% |
| Dec 31, 2021 | 4,303.95% |
| Sep 30, 2021 | 141.53% |
| Jun 30, 2021 | -112.79% |